Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gaston

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Atherosclerosis|October 31, 2006
T-cell reactivity against HSP60 relates to early but not advanced atherosclerosisM Knoflach, S Kiechl, B Mayrl, et al.
Annals of the Rheumatic Diseases|November 18, 2004
Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active transcription of tumour necrosis factor alpha and interferon gammaM Rihl, J Gu, D Baeten, et al.
Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIIIT D Jones, W J Phillips, B J Smith, et al.
European Journal of Immunology|June 28, 2007
IFN-gamma regulates Fas ligand expression in human CD4+ T lymphocytes and controls their anti-mycobacterial cytotoxic functionsDaniela Boselli, Giuliana Losana, Paola Bernabei, et al.
Annals of the Rheumatic Diseases|August 17, 2004
Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled studyT K Kvien, J S H Gaston, T Bardin, et al.
Clinical Rheumatology|August 9, 2008
Reactive and undifferentiated arthritis in North Africa: use of PCR for detection of Chlamydia trachomatisJ G Kuipers, J Sibilia, S Bas, et al.
Nature Reviews. Disease Primers|March 16, 2018
Sickle cell diseaseGregory J Kato, Frédéric B Piel, Clarice D Reid, et al.
RMD Open|August 6, 2016
Long-term efficiency of infliximab in patients with ankylosing spondylitis: real life data confirm the potential for dose reductionX Baraliakos, F Heldmann, F van den Bosch, et al.
Annals of the Rheumatic Diseases|October 16, 2012
Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) studyJoachim Sieper, Shankar Srinivasan, Omid Zamani, et al.
Clinical and Experimental Rheumatology|September 13, 2011
The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximabF Heldmann, J Brandt, I E van der Horst-Bruinsma, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Atherosclerosis|October 31, 2006
T-cell reactivity against HSP60 relates to early but not advanced atherosclerosisM Knoflach, S Kiechl, B Mayrl, et al.
Annals of the Rheumatic Diseases|November 18, 2004
Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active transcription of tumour necrosis factor alpha and interferon gammaM Rihl, J Gu, D Baeten, et al.
Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIIIT D Jones, W J Phillips, B J Smith, et al.
European Journal of Immunology|June 28, 2007
IFN-gamma regulates Fas ligand expression in human CD4+ T lymphocytes and controls their anti-mycobacterial cytotoxic functionsDaniela Boselli, Giuliana Losana, Paola Bernabei, et al.
Annals of the Rheumatic Diseases|August 17, 2004
Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled studyT K Kvien, J S H Gaston, T Bardin, et al.
Clinical Rheumatology|August 9, 2008
Reactive and undifferentiated arthritis in North Africa: use of PCR for detection of Chlamydia trachomatisJ G Kuipers, J Sibilia, S Bas, et al.
Nature Reviews. Disease Primers|March 16, 2018
Sickle cell diseaseGregory J Kato, Frédéric B Piel, Clarice D Reid, et al.
RMD Open|August 6, 2016
Long-term efficiency of infliximab in patients with ankylosing spondylitis: real life data confirm the potential for dose reductionX Baraliakos, F Heldmann, F van den Bosch, et al.
Annals of the Rheumatic Diseases|October 16, 2012
Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) studyJoachim Sieper, Shankar Srinivasan, Omid Zamani, et al.
Clinical and Experimental Rheumatology|September 13, 2011
The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximabF Heldmann, J Brandt, I E van der Horst-Bruinsma, et al.
Pageof 7